[ACRX] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
01-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 16.02%
YoY- -17.73%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 2,924 941 818 2,659 4,531 1,924 71 85.72%
PBT -6,602 -12,409 -10,539 -13,057 -11,092 -8,896 -10,575 -7.54%
Tax 4 3 2 2 -2,083 777 2,215 -65.07%
NP -6,606 -12,412 -10,541 -13,059 -11,092 -8,896 -10,575 -7.53%
Tax Rate - - - - - - - -
Total Cost 9,530 13,353 11,359 15,718 15,623 10,820 10,646 -1.82%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin -225.92 -1,319.02 -1,288.63 -491.12 -244.80 -462.37 -14,894.37 -50.21%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS -1.64 -3.15 -4.07 -5.76 -4.90 -4.01 -4.88 -16.60%
EPS Diluted -1.64 -3.15 -4.07 -5.76 -4.90 -4.01 -4.77 -16.28%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.